They Call It ‘Tranq,’ and It’s Making Street Drugs More Dangerous

Approaching a van that distributes supplies for safer drug use in Greenfield, Massachusetts, a man named Kyle noticed an alert about xylazine. “Xylazine?” he asked, sounding out the unfamiliar word. “Tell me more.” Tapestry Health Systems nurse Katy Robbins hands bottles of water to Kyle as he visits the harm reduction mobile unit in Greenfield, … Read more

FDA Denies Petition to Disqualify Researchers Over Controversial Ketamine Studies

The US Food and Drug Administration (FDA) has declined to take further action against a group of investigators at Hennepin County Medical Center/Hennepin Healthcare (HCMC), who conducted controversial studies involving ketamine and other sedatives in agitated persons without their consent. A citizen filed by Public Citizen, a consumer advocacy group, had asked the FDA to … Read more